Christopher Yallop
Fondateur chez Batavia Biosciences BV
Provenance du réseau au premier degré de Christopher Yallop
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 46 | |
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.
16
| Extinct | Pharmaceuticals: Major | 16 |
Batavia Biosciences BV
 Batavia Biosciences BV Pharmaceuticals: MajorHealth Technology Batavia Biosciences BV provides biopharmaceutical process development services. It offers biopharmaceutical materials research and pre-clinical study services for biopharmaceutical clients. The firm services cover candidate selection, production of research materials, upstream and downstream process development, assay development, product characterization and clinical manufacturing and release. The company was founded in 2010 and is headquartered in Leiden, the Netherlands.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Christopher Yallop via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Masters Business Admin Graduate Degree Graduate Degree | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Chairman President Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Chairman Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Chairman Private Equity Investor Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal President Director of Finance/CFO Director/Board Member | |
| Scandinavian International Management Institute | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Founder Chief Executive Officer Founder Chief Executive Officer | |
| University of Aarhus | College/University | Doctorate Degree Director/Board Member Graduate Degree Graduate Degree | |
| ALK-ABELLÓ A/S | Biotechnology | Chief Executive Officer Chairman Director/Board Member Director/Board Member | |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chief Executive Officer President Corporate Officer/Principal | |
| CURASIGHT A/S | Medical Specialties | Director/Board Member Chairman Chief Operating Officer | |
Janssen Vaccines & Prevention BV
 Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Chairman Chief Operating Officer Corporate Officer/Principal | |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| MERUS N.V. | Biotechnology | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Founder Director/Board Member Corporate Officer/Principal | |
| NNIT A/S | Information Technology Services | Chairman Director/Board Member Corporate Officer/Principal | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Hempel A/S
 Hempel A/S Industrial SpecialtiesProcess Industries Hempel A/S manufactures and supplies decorative paints and antifouling products. It is a coatings supplier for the decorative, protective, marine, container and yacht markets. The company was founded in 1915 and is headquartered in Kongens Lyngby, Denmark. | Industrial Specialties | Director/Board Member Director/Board Member | |
GN Hearing A/S
 GN Hearing A/S Medical SpecialtiesHealth Technology GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark. | Medical Specialties | Chief Executive Officer Director/Board Member | |
| University of Gothenburg | College/University | Doctorate Degree Doctorate Degree | |
Polyganics BV
 Polyganics BV Medical SpecialtiesHealth Technology Polyganics BV engages in the development, manufacture, and commercialization of bioresorbable medical devices that facilitate tissue repair and regeneration. It offers pipeline, peripheral nerve repair, neurosurgery, and general surgery products . The company was founded in 1999 and is headquartered in Groningen, the Netherlands. | Medical Specialties | Director/Board Member Chairman | |
Xellia Pharmaceuticals ApS
 Xellia Pharmaceuticals ApS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member | |
New Xellia Group A/S
 New Xellia Group A/S Financial ConglomeratesFinance New Xellia Group A/S operates as an investment holding Danish company. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Chairman Director/Board Member | |
| University of Lund | College/University | Corporate Officer/Principal Graduate Degree | |
| University of Leiden | College/University | Doctorate Degree Doctorate Degree | |
| GN STORE NORD A/S | Telecommunications Equipment | Chief Executive Officer Director/Board Member | |
Aurigene Discovery Technologies Ltd.
 Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. | Biotechnology | Director/Board Member Director/Board Member | |
Bioneer A/S
 Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Graduate Degree | |
NNE A/S
 NNE A/S Engineering & ConstructionIndustrial Services Part of Novo Nordisk A/S, NNE A/S is a Danish company that supplies systems, consultancy and engineering services. The company is based in Soborg, Denmark. | Engineering & Construction | Director/Board Member Chairman | |
| AP MOLLER MAERSK | Marine Shipping | Corporate Officer/Principal Corporate Officer/Principal | |
International N&H Denmark ApS
 International N&H Denmark ApS Food: Major DiversifiedConsumer Non-Durables DuPont Nutrition Biosciences ApS is engaged in the production of food enzymes, products and pharmaceutical grade excipients for food products. It operates through the following divisions: Enablers, BioActives, Sweeteners, Cultures, Genecor and Sales and Application Food Ingredients. The Enablers division develops, produces and markets emulsifiers, hydrocolloids, and tailored systems that enable food & beverage manufactureres to make appealing products. The BioActives division is comprised of the Cultures and Sweeteners divisions. It offers food cultures and protective solutions, speciality sweeteners, health ingredients, and microorganisms for agriculture and animal nutrition. The Genencor division develops innovative enzymes and bioproducts to reduce the environmental impact of the cleaning, textile, fuel, and chemical industries. The sales and Application food Ingredients division manages and budgets global key accounts. The company was founded in 1989 and is headquartered Copenhagen, Denmark | Food: Major Diversified | Director/Board Member Director/Board Member | |
Svenskt Näringsliv
 Svenskt Näringsliv Miscellaneous Commercial ServicesCommercial Services Svenskt Näringsliv provides consulting services. It focuses on protection, support, and promotion of the interests of businesses. The firm provides its members with knowledge in a number of areas including labor market and law, taxes, corporate law and intellectual property, economics and macro analysis, constitutional and legal protection, security and risk management, and trade policy. The company was founded on March 29, 2001 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| CORBION N.V. | Food: Specialty/Candy | Director/Board Member Director/Board Member | |
| University of Utrecht | College/University | Corporate Officer/Principal Doctorate Degree | |
| Hubrecht Organoid Technology Foundation | Director/Board Member Chief Executive Officer | ||
DCPrime BV
 DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
PricewaterhouseCoopers (Denmark)
 PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a company based in Hellerup, Denmark. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| FORWARD PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistiques
Internationale
| Danemark | 33 |
| Pays-Bas | 10 |
| Etats-Unis | 5 |
| Suède | 4 |
| Norvège | 2 |
Sectorielle
| Health Technology | 25 |
| Consumer Services | 11 |
| Finance | 4 |
| Commercial Services | 4 |
| Process Industries | 3 |
Opérationnelle
| Director/Board Member | 336 |
| Corporate Officer/Principal | 155 |
| Chairman | 137 |
| Independent Dir/Board Member | 83 |
| Chief Executive Officer | 78 |
Relations les plus connectées
| Insiders | |
|---|---|
| Jack Nielsen | 38 |
| Anders Hedegaard | 30 |
| Jesper Brandgaard | 28 |
| Bruce Carter | 25 |
| Martin Olin | 25 |
| Anker Gunvald Lundemose | 25 |
| Jens Jesper Ovesen | 25 |
| Thomas Dyrberg | 24 |
| Steen Riisgaard | 24 |
| Anna Héléne Barnekow | 24 |
| Jan Ulf Sigvar J. Johansson | 23 |
| Cees de Jong | 23 |
| Stephen Brown Davis | 21 |
| Thomas Feldthus | 20 |
| Peter Nordkild | 20 |
- Bourse
- Insiders
- Christopher Yallop
- Connexions Sociétés
